Study to Evaluate Safety and Efficacy of Ck3773274 | Clinical Research Studies Listing

Recruiting

18 years - 99 years

All

Phase 3

5 participants needed

1 Location

Brief description of study

The purpose of this study is to compare the effects of CK-3773274, and placebo, on the exercise and health status of patients with oHCM. The safety and tolerability of CK-3773274 will also be studied.

Detailed description of study

The study will also measure the amount of CK-3773274 in your blood at various times, and the effect the study drug may have on your oHCM. CK-3773274 is an investigational (experimental) study drug. This means that CK 3773274 has not been approved by the U.S. Food and Drug Administration (FDA), for use outside of a research study. Your participation in this research will involve at least 10 visits to the research site. The research study will last about 34 weeks (8 months). This time estimate includes the screening period to evaluate if you can participate in the study, the treatment period and the follow up period after the last treatment.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research, Heart, Symptomatic Hypertrophic Cardiomyopathy, Left Ventricular Outflow Tract Obstruction, oHCM
Age: 18 years - 99 years
Gender: All

Diagnosed with obstructive hypertrophic cardiomyopathy (oHCM)

Updated on 04 Aug 2024. Study ID: 849952

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study to Evaluate Safety and Efficacy of Ck3773274 in Adults with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Brief description of study

Detailed description of study

Eligibility of study

Find a site

Interested in the study